GeneDx Holdings Corp. WGS

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $84.05
Market Cap $2.50B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑40.0% YoY
$427.54M
3-Yr CAGR: 22.1%
Net Income
N/A
Net Margin: N/A
Free Cash Flow ↑142.0% YoY
$14.26M
FCF Yield: 0.57%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: N/A

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (WGS)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2019 $196.2M $82.8M $-18.7M $-30.7M
FY 2020 $179.3M -8.6% $4.0M 0.00% $-0.4M $-24.5M +20.1%
FY 2021 $212.2M +18.3% $-16.6M 0.00% $-190.4M $-199.8M -716.3%
FY 2022 $234.7M +10.6% $-26.8M 0.00% $-319.2M $-326.3M -63.3%
FY 2023 $202.6M -13.7% $90.0M 0.00% $-180.1M $-185.4M +43.2%
FY 2024 $305.4M +50.8% $194.4M 0.00% $-28.5M $-34.0M +81.7%
FY 2025 $427.5M +40.0% $298.2M 0.00% $33.3M $14.3M +142.0%
$

Valuation

Market Price $84.05
Market Cap $2.50B
Enterprise Value $2.44B
P/E Ratio N/A
P/B Ratio 8.10
FCF Yield 0.57%
Dividend Yield N/A
Shares Outstanding 29,688,000
%

Profitability & Margins

Gross Margin 69.74%
Operating Margin N/A
Net Margin N/A
Return on Equity (ROE) N/A
Return on Assets (ROA) N/A
Asset Turnover 0.82x
Revenue 3-Yr CAGR 22.13%
🛡️

Financial Health & Liquidity

Current Ratio 2.46
Cash Ratio 0.96
Debt / Equity 0.171
Debt / Assets 0.101
Cash & Equivalents $105.00M
Total Debt $52.72M
Book Value / Share $10.38
💧

Cash Flow Efficiency

Operating Cash Flow $33.28M
Capital Expenditures (CapEx) $19.02M
Free Cash Flow $14.26M
OCF / Revenue 7.78%
FCF / Revenue 3.34%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $10.38
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $523.71M
Total Liabilities $215.53M
Stockholders' Equity $308.18M
Current Assets $268.29M
Current Liabilities $108.91M